These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16416115)

  • 1. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary plasma cell leukemia occuring in the young.
    Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
    Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma cell leukemia. Study of 6 patients].
    Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
    Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
    Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
    Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell leukemia. A report on 11 patients and review of the literature.
    Pasqualetti P; Festuccia V; Collacciani A; Acitelli P; Casale R
    Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
    Katodritou E; Terpos E; Kelaidi C; Kotsopoulou M; Delimpasi S; Kyrtsonis MC; Symeonidis A; Giannakoulas N; Stefanoudaki A; Christoulas D; Chatziaggelidou C; Gastari V; Spyridis N; Verrou E; Konstantinidou P; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Feb; 89(2):145-50. PubMed ID: 24123068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary plasma cell leukemia. A fulminant case].
    Famularo G; Armentano C; Mechelli A; De Laurenzi A; Nicotra GC
    Recenti Prog Med; 2003 Feb; 94(2):66-8. PubMed ID: 12908372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
    Peijing Q; Yan X; Yafei W; Dehui Z; Zengjun L; Junyuan Q; Yaozhong Z; Lugui Q
    Acta Haematol; 2009; 121(1):47-51. PubMed ID: 19339770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
    Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
    Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary plasma cell leukemia--a comprehensive analysis of 44 cases].
    Cai ZJ
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):314-7. PubMed ID: 2272272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.
    Saccaro S; Fonseca R; Veillon DM; Cotelingam J; Nordberg ML; Bredeson C; Glass J; Munker R
    Am J Hematol; 2005 Apr; 78(4):288-94. PubMed ID: 15795922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma cell leukemia: our experience in 4 cases].
    Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
    Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
    Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
    Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic aberrations and survival in plasma cell leukemia.
    Tiedemann RE; Gonzalez-Paz N; Kyle RA; Santana-Davila R; Price-Troska T; Van Wier SA; Chng WJ; Ketterling RP; Gertz MA; Henderson K; Greipp PR; Dispenzieri A; Lacy MQ; Rajkumar SV; Bergsagel PL; Stewart AK; Fonseca R
    Leukemia; 2008 May; 22(5):1044-52. PubMed ID: 18216867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cell leukemia.
    Kosmo MA; Gale RP
    Semin Hematol; 1987 Jul; 24(3):202-8. PubMed ID: 3116673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
    Wang H; Zhou H; Zhang Z; Geng C; Chen W
    Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.